A Study of Subcutaneously-administered Guselkumab Delivered by 3 Different Devices in Healthy Participants

Inclusion Criteria

• •Have a weight in the range of 50.0 kilogram (kg) to 90.0 kg, inclusive
• •Be healthy on the basis of physical examination, medical history, vital signs, and 12 lead electrocardiogram (ECG) performed at screening and Day -1. Any abnormalities must be considered not clinically significant and this determination must be recorded in the participant's source documents and initialed by the investigator
• •A female participant must have a negative pregnancy test result at screening and baseline (Day -1) and while enrolled in this study
• •Contraceptive (birth control) use by men should be consistent with local regulations (if any) regarding the acceptable methods of contraception for those participating in clinical studies
• •A woman must agree not to donate eggs (ova, oocytes) for the purposes of assisted reproduction during the study and for a period of 12 weeks after study intervention